skip to navigation skip to content
Search

SPIREA

Business Weekly: Seeds of a revolution as Spirea plans to reshape cancer treatment

Spirea startup, supported by the Accelerate Cambridge programme run by Cambridge Judge’s Entrepeneurship Centre, has raised crucial funding and is aiming to target a potential $7.5 billion market for the treatment of multiple cancers. CEO Myriam Ouberai said: “Incorporation of…

Read more

Cambridge Network: BioBeat unveils 2018’s 50 Movers and Shakers

BioBeat has released its 50 Movers and Shakers in BioBusiness 2018 list of female leaders in healthcare, which includes several women with Cambridge Judge connections. They include Miriam Ouberai of SPIREA, Zuzanna Brzosko of Sixfold Bioscience, and Anya Roy of…

Read more

Peptide therapeutics progress

Journal article on peptides co-authored by the co-founder of Accelerate Cambridge healthcare venture wins MedImmune 2017 Global Excellence Award for best publication. A journal article on peptides co-authored by the co-founder of a healthcare technology venture mentored on the Accelerate…

Read more

2018 News: Peptide therapeutics progress.

Archives